SCHEMBL14218140

SCHEMBL14218140

CCN1CCN(C(=O)Cc2sc3ccc(Cl)cc3c2C)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.54
HSD11B1 P28845 1/20 0.45
LMNA P02545 4/20 0.43
NPSR1 Q6W5P4 2/20 0.43
THRB P10828 2/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 1/20 0.41
KMT2A Q03164 2/20 0.40
HPGD P15428 1/20 0.40
DUSP3 P51452 1/20 0.40
PTPN5 P54829 1/20 0.40
PTPN11 Q06124 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
GAA P10253 2/20 0.40
TSHR P16473 1/20 0.40
CNR1 P21554 1/20 0.40
ALPL P05186 1/20 0.40
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4380469 0.87 MAPT (0.50) MAPTLMNANPSR1RAB9ANPC1
SCHEMBL4380711 0.83 MAPT (0.50) MAPTALDH1A1KDM4EHPGD
SCHEMBL4380482 0.82 MAPT (0.49) MAPTLMNATHRBRAB9ANPC1
SCHEMBL2834155 0.81 MAPT (0.50) MAPTNPSR1
Tianafac SCHEMBL2109723 0.76 MAPT (0.67) MAPTNPSR1ALDH1A1KDM4EKMT2A
SCHEMBL107073 0.75 ENPP2 (0.55) MAPTLMNAALDH1A1KDM4EKMT2A
Hydrochloric Acid SCHEMBL9050783 0.73 MAPT (0.49) MAPTLMNARAB9ANPC1ALDH1A1
SCHEMBL10091955 0.71 MAPT (0.56) MAPTNPSR1KDM4E
SCHEMBL3148840 0.70 HTR6 (0.53) MAPTKMT2A
SCHEMBL7018255 0.70 MAPT (0.59) MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113968-A1 Substituted piperazines and diazepanes HRH3, HRH4, HRH1 MAPT 1441/4885HSD11B1 2071/4885LMNA 4304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.